- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI)
Total 20 results
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteGermany, France, United States
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteUnited States, France
-
GlaxoSmithKlineTerminatedMelanomaNorway, Argentina, Greece
-
Jules Bordet InstituteUnknownEffects of Immunotherapy | Acute Myelogenous Leukemia | Myeloid Leukemia in RemissionBelgium
-
GlaxoSmithKlineCompletedMelanomaFrance, Italy, Germany, Netherlands, Switzerland, United Kingdom, Austria, Australia
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; GlaxoSmithKline and other collaboratorsCompletedMultiple MyelomaUnited States
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Australia, Canada, Netherlands, Finland, Taiwan, Czechia, Estonia, Spain, Argentina, Belgium, France, Sweden, Germany, Israel, Italy, Korea, Republic of, Singapore, Ukraine, United Kingdom, Austria, Ireland, Thailand, C... and more
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute LeukemiaUnited States
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
OHSU Knight Cancer InstituteAbbVie; Oregon Health and Science UniversityRecruitingB Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States
-
National Cancer Institute (NCI)RecruitingDown Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
University of WashingtonNovartis; Institute for Prostate Cancer Research (IPCR)Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Puerto Rico, Israel
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
National Cancer Institute (NCI)Not yet recruiting
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States, Canada, Israel, Puerto Rico
-
National Cancer Institute (NCI)RecruitingPrimary Mediastinal Large B-Cell LymphomaUnited States, Canada, Australia, Puerto Rico